Danazol inhibition of steroidogenesis in the human corpus luteum

Abstract

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (13)

• Endometriosis 2019
• Medical treatment of ureteral obstruction associated with ovarian remnants and/or endometriosis: report of three cases and review of the literature 2014
• Medical Treatment in Endometriosis 2012
• Benefits and risks of pharmacological agents used for the treatment of menorrhagia 2004
• Altered uterine artery blood flow impedance after danazol therapy: possible mode of action in dysfunctional uterine bleeding 1999
• Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells 1993
• Progesterone receptor induction by danazol in cultured cancer cells and the rat uterus 1992
• The use of danazol as a treatment of endometriosis 1991
• Inhibition of rat ovarian 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD), 17 alpha-hydroxylase and 17,20 lyase by progestins and danazol 1989
• The treatment of glucocorticosteroid-dependent chronic urticaria with stanozolol 1988
• Danazol in menorrhagia: a double blind placebo controlled trial 1987
• Danazol inhibits steroidogenesis by the human ovary in vivo 1986
• Effect of danazol on gonadal steroidogenesis in patients with a complete form of testicular feminization 1982

Source provenance

openalex

last seen: 2026-05-10T11:00:11.550629+00:00

pubmed

last seen: 2026-10-08T21:58:32.052686+00:00